Document is current
Any future updates will be listed below
-
Authors
Weaver, Danielle
Novak-Frazer, Lilyann
Palmer, Maisie
Richardson, Malcolm
Bromley, Mike
Bowyer, Paul
-
Funding
Funding for this research was provided by:
Manchester Biomedical Research Centre (NIHR203308, NIHR203308)
- License Information
-
More Information
Article History
Received: 31 August 2023
Accepted: 12 January 2024
First Online: 19 February 2024
Declarations
:
: Not applicable.
: Using the Health Research Authority system [CitationRef removed], this study was confirmed to not require ethics review.
: MJB is a director and shareholder of Syngenics Limited, PiQ laboratories Ltd and inpepcide Ltd. He is also a consultant for Rostra Ltd and had received funds from F2g Ltd outside the submitted work. MR is a shareholder in Richardson Bio-Tech. The remaining authors declare that they have no competing interests.
